select a format

Single User License
USD 1500 INR 96060
Site License
USD 3000 INR 192120
Corporate User License
USD 4500 INR 288180

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


NewLink Genetics Corporation-Product Pipeline Review-2015

NewLink Genetics Corporation-Product Pipeline Review-2015


  • Products Id :- GMDHC07195CDB
  • |
  • Pages: 51
  • |
  • July 2015
  • |
  • |
  Request for Sample Report

Executive Summary

NewLink Genetics Corporation-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'NewLink Genetics Corporation-Product Pipeline Review-2015', provides an overview of the NewLink Genetics Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NewLink Genetics Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of NewLink Genetics Corporation including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of NewLink Genetics Corporation's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the NewLink Genetics Corporation's pipeline products

Reasons To Buy

Evaluate NewLink Genetics Corporation's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of NewLink Genetics Corporation in its therapy areas of focus

Identify new drug targets and therapeutic classes in the NewLink Genetics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of NewLink Genetics Corporation and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of NewLink Genetics Corporation

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of NewLink Genetics Corporation and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

NewLink Genetics Corporation Snapshot 6

NewLink Genetics Corporation Overview 6

Key Information 6

Key Facts 6

NewLink Genetics Corporation-Research and Development Overview 7

Key Therapeutic Areas 7

NewLink Genetics Corporation-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

NewLink Genetics Corporation-Pipeline Products Glance 14

NewLink Genetics Corporation-Late Stage Pipeline Products 14

Phase III Products/Combination Treatment Modalities 14

NewLink Genetics Corporation-Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Phase I Products/Combination Treatment Modalities 16

NewLink Genetics Corporation-Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

NewLink Genetics Corporation-Drug Profiles 19

algenpantucel-L 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

tergenpumatucel-L 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

dorgenmeltucel-L 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

indoximod 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Cell Therapy for Prostate Cancer 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Cell Therapy for Renal Cancer 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

influenza [strain H1N1] vaccine 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

influenza [strain H5N1] vaccine 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

influenza [strain H7N9] vaccine 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Small Molecules to Inhibit IDO and TDO for Cancer 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Small Molecules to Inhibit IDO Pathway for Cancer 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Small Molecules to Inhibit TDO for Cancer 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

yellow fever and arenavirus vaccine 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

NewLink Genetics Corporation-Pipeline Analysis 35

NewLink Genetics Corporation-Pipeline Products by Target 35

NewLink Genetics Corporation-Pipeline Products by Route of Administration 36

NewLink Genetics Corporation-Pipeline Products by Molecule Type 37

NewLink Genetics Corporation-Pipeline Products by Mechanism of Action 38

NewLink Genetics Corporation-Recent Pipeline Updates 39

NewLink Genetics Corporation-Dormant Projects 46

NewLink Genetics Corporation-Company Statement 47

NewLink Genetics Corporation-Locations And Subsidiaries 49

Head Office 49

Other Locations & Subsidiaries 49

Appendix 50

Methodology 50

Coverage 50

Secondary Research 50

Primary Research 50

Expert Panel Validation 50

Contact Us 50

Disclaimer 51

List of Tables

NewLink Genetics Corporation, Key Information 6

NewLink Genetics Corporation, Key Facts 6

NewLink Genetics Corporation-Pipeline by Indication, 2015 8

NewLink Genetics Corporation-Pipeline by Stage of Development, 2015 10

NewLink Genetics Corporation-Monotherapy Products in Pipeline, 2015 11

NewLink Genetics Corporation-Out-Licensed Products in Pipeline, 2015 12

NewLink Genetics Corporation-Out-Licensed Products/ Combination Treatment Modalities, 2015 13

NewLink Genetics Corporation-Phase III, 2015 14

NewLink Genetics Corporation-Phase II, 2015 15

NewLink Genetics Corporation-Phase I, 2015 16

NewLink Genetics Corporation-Preclinical, 2015 17

NewLink Genetics Corporation-Discovery, 2015 18

NewLink Genetics Corporation-Pipeline by Target, 2015 35

NewLink Genetics Corporation-Pipeline by Route of Administration, 2015 36

NewLink Genetics Corporation-Pipeline by Molecule Type, 2015 37

NewLink Genetics Corporation-Pipeline Products by Mechanism of Action, 2015 38

NewLink Genetics Corporation-Recent Pipeline Updates, 2015 39

NewLink Genetics Corporation-Dormant Developmental Projects,2015 46

NewLink Genetics Corporation, Subsidiaries 49

List of Figures

NewLink Genetics Corporation-Pipeline by Top 10 Indication, 2015 8

NewLink Genetics Corporation-Pipeline by Stage of Development, 2015 10

NewLink Genetics Corporation-Monotherapy Products in Pipeline, 2015 11

NewLink Genetics Corporation-Out-Licensed Products in Pipeline, 2015 12

NewLink Genetics Corporation-Pipeline by Top 10 Target, 2015 35

NewLink Genetics Corporation-Pipeline by Top 10 Route of Administration, 2015 36

NewLink Genetics Corporation-Pipeline by Top 10 Molecule Type, 2015 37

NewLink Genetics Corporation-Pipeline Products by Top 10 Mechanism of Action, 2015 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of NewLink Genetics Corporation; NewLink Genetics Corporation - Key Therapeutics; NewLink Genetics Corporation - Pipeline Overview and Promising Molecules; NewLink Genetics Corporation - News; NewLink Genetics Corporation - Latest Updates; NewLink Genetics Corporation - Pipeline; NewLink Genetics Corporation - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com